LYRA
Lyra Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.20
+0.00%Leverage
- Debt / equity
- -2.82x
- Net debt / equity
- -1.34x
- Debt / assets
- 0.84x
- Debt / EBITDA
- -0.98x
- Net debt / EBITDA
- -0.46x
Liquidity & coverage
- Current ratio
- 1.71x
- Quick ratio
- 1.71x
- Cash ratio
- 1.67x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $6.8M
Cash & dividend
- FCF / debt
- -0.96x
- Cash flow / debt
- -0.95x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Dec 1, 2025